KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Goodwill & Intangibles (2018 - 2025)

Twist Bioscience (TWST) has disclosed Goodwill & Intangibles for 8 consecutive years, with $95.4 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 4.67% to $95.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95.4 million through Dec 2025, down 4.67% year-over-year, with the annual reading at $95.6 million for FY2025, 4.66% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $95.4 million at Twist Bioscience, roughly flat from $95.6 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $148.2 million in Q1 2022, with the low at $1.3 million in Q1 2021.
  • Average Goodwill & Intangibles over 5 years is $110.3 million, with a median of $119.1 million recorded in 2024.
  • The sharpest move saw Goodwill & Intangibles surged 10949.29% in 2022, then decreased 28.98% in 2024.
  • Over 5 years, Goodwill & Intangibles stood at $148.2 million in 2021, then decreased by 2.69% to $144.2 million in 2022, then dropped by 3.59% to $139.0 million in 2023, then fell by 28.04% to $100.0 million in 2024, then dropped by 4.67% to $95.4 million in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $95.4 million, $95.6 million, and $95.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.